Sebastian Schaefer | Co-Founder
Enleofen Bio Pte Ltd | Singapore

Sebastian Schaefer, Co-Founder, Enleofen Bio Pte Ltd

Sebastian Schäfer is a Co-founder of Enleofen Bio, a Singaporean biotech company developing first-in-class antibody therapeutics for the treatment of fibro-inflammatory diseases.


Phar East 2020 Agenda Day One @ 11:30

Enleofen Bio: First-in-class Therapeutics for Fibro-inflammatory Diseases

last published: 10/Jun/20 01:56 GMT

back to speakers






For speaking, sponsorship and exhibition opportunities contact
Tel: +65 6322 2738